Dr Mercè Boada, medical director of Fundació ACE, has participated in the opening symposium of the South Texas Alzheimer’s Conference 2020 (STAC 2020), a meeting organized by the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, and in partnership with the Alzheimer's Association.
The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio is the region’s first comprehensive center dedicated to transforming dementia care through patient care, resources and innovative research and clinical trials.
The inaugural conference where Dr Boada has taken part has been entitled "New hopes and discoveries for the treatment and prevention of Alzheimer's and other dementias". Other renowned figures from the world of research in this field have also participated in this symposium, such as Dr. Sudha Seshadri, founding director of the Glenn Biggs Institute.
Dr Agustín Ruiz, Research Director of Fundació ACE, has also participed in the conference in South Texas. Dr Ruiz has spoken about the GR@ACE project (Genome Research at ACE Foundation), a study of human genetics based on the application of High resolution genomic technologies to identify new genes that cause Alzheimer's disease in order to find treatments that fight it. GR@ACE, which has the impulse of the Obra Social "la Caixa" and Grifols, is currently the study with the highest number of genomic samples conducted in Spain.